China Antidiabetic Biguanides Industry 2016 Market Research Report

Published Date : 2016-02-11

Published By : QY Research Reports

Category : Pharma & Healthcare

No. of Pages : 138

The China Antidiabetic Biguanides Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Antidiabetic Biguanides industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Antidiabetic Biguanides market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on China major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Antidiabetic Biguanides industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 154 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents



1 Industry Overview

1.1 Definition and Specifications of Antidiabetic Biguanides

1.2 Classification of Antidiabetic Biguanides

1.2.1 Designed for Gas

1.2.2 Designed for Air

1.2.3 Designed for Breathing Air

1.2.4 Designed for Particulate

1.2.5 Not Specified

1.3 Applications of Antidiabetic Biguanides

1.4 Industry Chain Structure of Antidiabetic Biguanides

1.5 Industry Overview of Antidiabetic Biguanides

1.6 Industry Policy Analysis of Antidiabetic Biguanides

1.7 Industry News Analysis of Antidiabetic Biguanides



2 Manufacturing Cost Structure Analysis of Antidiabetic Biguanides

2.1 Bill of Materials (BOM) of Antidiabetic Biguanides

2.2 BOM Price Analysis of Antidiabetic Biguanides

2.3 Labor Cost Analysis of Antidiabetic Biguanides

2.4 Depreciation Cost Analysis of Antidiabetic Biguanides

2.5 Manufacturing Cost Structure Analysis of Antidiabetic Biguanides

2.6 Manufacturing Process Analysis of Antidiabetic Biguanides

2.7 China Price, Cost and Gross of Antidiabetic Biguanides 2011-2016



3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of China Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of China Key Antidiabetic Biguanides Manufacturers in 2015

3.3 R&D Status and Technology Source of China Antidiabetic Biguanides Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of China Antidiabetic Biguanides Key Manufacturers in 2015



4 Production Analysis of Antidiabetic Biguanides by Regions, Type, and Applications

4.1 China Production of Antidiabetic Biguanides by Regions 2011-2016

4.2 China Production of Antidiabetic Biguanides by Type 2011-2016

4.3 China Sales of Antidiabetic Biguanides by Applications 2011-2016

4.4 Price Analysis of China Antidiabetic Biguanides Key Manufacturers in 2015

4.5 China Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Antidiabetic Biguanides 2011-2016



5 Consumption Volume and Consumption Value Analysis of Antidiabetic Biguanides by Regions

5.1 China Consumption Volume of Antidiabetic Biguanides by Regions 2011-2016

5.2 China Consumption Value of Antidiabetic Biguanides by Regions 2011-2016

5.3 China Consumption Price Analysis of Antidiabetic Biguanides by Regions 2011-2016



6 Analysis of Antidiabetic Biguanides Production, Supply, Sales and Market Status 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Antidiabetic Biguanides 2011-2016

6.2 Production Market Share and Sales Market Share Analysis of Antidiabetic Biguanides 2014-2015

6.3 Sales Overview of Antidiabetic Biguanides 2011-2016

6.4 Supply, Consumption and Gap of Antidiabetic Biguanides 2011-2016

6.5 Import, Export and Consumption of Antidiabetic Biguanides 2011-2016

6.6 Cost, Price, Revenue and Gross Margin of Antidiabetic Biguanides 2011-2016



7 Analysis of Antidiabetic Biguanides Industry Key Manufacturers

7.1 Sanofi

7.1.1 Company Profile

7.1.2 Product Picture and Specification

7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.1.4 Sanofi SWOT Analysis



7.2 Takeda Pharmaceuticals

7.2.1 Company Profile

7.2.2 Product Picture and Specification

7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.2.4 Takeda Pharmaceuticals SWOT Analysis



7.3 Eli Lilly

7.3.1 Company Profile

7.3.2 Product Picture and Specification

7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.3.4 Eli Lilly SWOT Analysis



7.4 Merck & Co.

7.4.1 Company Profile

7.4.2 Product Picture and Specification

7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.4.4 Merck & Co. SWOT Analysis



7.5 Novo Nordisk

7.5.1 Company Profile

7.5.2 Product Picture and Specification

7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.5.4 Novo Nordisk SWOT Analysis



7.6 Bristol-Myers Squibb

7.6.1 Company Profile

7.6.2 Product Picture and Specification

7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.6.4 Bristol-Myers Squibb SWOT Analysis



7.7 Pfizer

7.7.1 Company Profile

7.7.2 Product Picture and Specification

7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.7.4 Pfizer SWOT Analysis



7.8 AstraZeneca

7.8.1 Company Profile

7.8.2 Product Picture and Specification

7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.8.4 AstraZeneca SWOT Analysis



7.9 GlaxoSmithKline

7.9.1 Company Profile

7.9.2 Product Picture and Specification

7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.9.4 GlaxoSmithKline SWOT Analysis



7.10 Boehringer Ingelheim

7.10.1 Company Profile

7.10.2 Product Picture and Specification

7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.10.4 Boehringer Ingelheim SWOT Analysis



8 Price and Gross Margin Analysis

8.1 Analysis of Price

8.2 Gross Margin Analysis

8.3 Price Comparison by Regions

8.4 Price Analysis of Different Antidiabetic Biguanides Product Types

8.5 Market Share Analysis of Different Antidiabetic Biguanides Price Levels

8.6 Gross Margin Analysis of Different Antidiabetic Biguanides Applications



9 Marketing Trader or Distributor Analysis of Antidiabetic Biguanides

9.1 Marketing Channels Status of Antidiabetic Biguanides

9.2 Traders or Distributors of Antidiabetic Biguanides with Contact Information

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Antidiabetic Biguanides

9.4 China Import, Export and Trade Analysis of Antidiabetic Biguanides



10 Development Trend of Antidiabetic Biguanides Industry 2016-2021

10.1 Capacity and Production Overview of Antidiabetic Biguanides 2016-2021

10.2 Production Market Share by Product Types of Antidiabetic Biguanides 2016-2021

10.3 Sales and Sales Revenue Overview of Antidiabetic Biguanides 2016-2021

10.4 China Sales of Antidiabetic Biguanides by Applications 2016-2021

10.5 Import, Export and Consumption of Antidiabetic Biguanides 2016-2021

10.6 Cost, Price, Revenue and Gross Margin of Antidiabetic Biguanides 2016-2021



11 Industry Chain Suppliers of Antidiabetic Biguanides with Contact Information

11.1 Major Raw Materials Suppliers of Antidiabetic Biguanides with Contact Information

11.2 Manufacturing Equipment Suppliers of Antidiabetic Biguanides with Contact Information

11.3 Major Players of Antidiabetic Biguanides with Contact Information

11.4 Key Consumers of Antidiabetic Biguanides with Contact Information

11.5 Supply Chain Relationship Analysis of Antidiabetic Biguanides



12 New Project Investment Feasibility Analysis of Antidiabetic Biguanides

12.1 New Project SWOT Analysis of Antidiabetic Biguanides

12.2 New Project Investment Feasibility Analysis of Antidiabetic Biguanides



13 Conclusion of the China Antidiabetic Biguanides Industry 2016 Market Research Report






List of Tables and Figures



Figure Picture of Antidiabetic Biguanides

Table Product Specifications of Antidiabetic Biguanides

Table Classification of Antidiabetic Biguanides

Figure China Sales Market Share of Antidiabetic Biguanides by Product Types in 2015

Table Applications of Antidiabetic Biguanides

Figure China Sales Market Share of Antidiabetic Biguanides by Applications in 2015

Figure Industry Chain Structure of Antidiabetic Biguanides

Table China Industry Overview of Antidiabetic Biguanides

Table Industry Policy of Antidiabetic Biguanides

Table Industry News List of Antidiabetic Biguanides

Table Bill of Materials (BOM) of Antidiabetic Biguanides

Table Bill of Materials (BOM) Price of Antidiabetic Biguanides

Table Labor Cost of Antidiabetic Biguanides

Table Depreciation Cost of Antidiabetic Biguanides

Table Manufacturing Cost Structure Analysis of Antidiabetic Biguanides in 2015

Figure Manufacturing Process Analysis of Antidiabetic Biguanides

Table China Price Analysis of Antidiabetic Biguanides 2011-2016 (USD/Dose)

Table China Cost Analysis of Antidiabetic Biguanides 2011-2016 (USD/Dose)

Table China Gross Analysis of Antidiabetic Biguanides 2011-2016

Table Capacity (Dose) and Commercial Production Date of China Antidiabetic Biguanides Key Manufacturers in 2015

Table Manufacturing Plants Distribution of China Key Antidiabetic Biguanides Manufacturers in 2015

Table R&D Status and Technology Source of China Antidiabetic Biguanides Key Manufacturers in 2015

Table Raw Materials Sources Analysis of China and China Antidiabetic Biguanides Key Manufacturers in 2015

Table China Production of Antidiabetic Biguanides by Regions 2011-2016 (Dose)

Table China Production Market Share of Antidiabetic Biguanides by Regions 2011-2016

Figure China Production Market Share of Antidiabetic Biguanides by Regions in 2014

Figure China Production Market Share of Antidiabetic Biguanides by Regions in 2015

Table China Production of Antidiabetic Biguanides by Types in 2011-2016 (Dose)

Table China Production Market Share of Antidiabetic Biguanides by Type in 2011-2016

Figure China Production Market Share of Antidiabetic Biguanides by Type in 2014

Figure China Production Market Share of Antidiabetic Biguanides by Type in 2015

Table China Sales of Antidiabetic Biguanides by Applications 2011-2016 (Dose)

Table China Production Market Share of Antidiabetic Biguanides by Applications 2011-2016

Figure China Production Market Share of Antidiabetic Biguanides by Applications in 2014

Figure China Production Market Share of Antidiabetic Biguanides by Applications in 2015

Table Price Comparison of China Antidiabetic Biguanides Key Manufacturers in 2015 (USD/Dose)

Table China Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Antidiabetic Biguanides 2011-2016

Table China Consumption Volume of Antidiabetic Biguanides by Regions 2011-2016 (Dose)

Table China Consumption Volume Market Share of Antidiabetic Biguanides by Regions 2011-2016

Figure China Consumption Volume Market Share of Antidiabetic Biguanides by Regions in 2014

Figure China Consumption Volume Market Share of Antidiabetic Biguanides by Regions in 2015

Table China Consumption Value of Antidiabetic Biguanides by Regions 2011-2016 (M USD)

Table China Consumption Value Market Share of Antidiabetic Biguanides by Regions 2011-2016

Figure China Consumption Value Market Share of Antidiabetic Biguanides by Regions in 2014

Figure China Consumption Value Market Share of Antidiabetic Biguanides by Regions in 2015

Table Consumption Price of Antidiabetic Biguanides by Regions 2011-2016 (USD/Dose)

Table China and Major Manufacturers Capacity of Antidiabetic Biguanides 2011-2016 (Dose)

Table China Capacity Market Share of Major Antidiabetic Biguanides Manufacturers 2011-2016

Table China and Major Manufacturers Production of Antidiabetic Biguanides 2011-2016 (Dose)

Table China Production Market Share of Major Antidiabetic Biguanides Manufacturers 2011-2016

Table China and Major Manufacturers Sales of Antidiabetic Biguanides 2011-2016 (Dose)

Table China Sales Market Share of Major Antidiabetic Biguanides Manufacturers 2011-2016

Table China and Major Manufacturers Sales Revenue of Antidiabetic Biguanides 2011-2016 (M USD)

Table China Sales Revenue Market Share of Major Antidiabetic Biguanides Manufacturers 2011-2016

Figure China Capacity (Dose), Production (Dose) and Growth Rate of Antidiabetic Biguanides 2011-2016

Figure China Capacity Utilization Rate of Antidiabetic Biguanides 2011-2016

Figure China Sales Revenue (M USD) and Growth Rate of Antidiabetic Biguanides 2011-2016

Figure China Production Market Share of Major Antidiabetic Biguanides Manufacturers in 2014

Figure China Production Market Share of Major Antidiabetic Biguanides Manufacturers in 2015

Figure China Sales Market Share of Major Antidiabetic Biguanides Manufacturers in 2014

Figure China Sales Market Share of Major Antidiabetic Biguanides Manufacturers in 2015

Figure China Sales (Dose) and Growth Rate of Antidiabetic Biguanides 2011-2016

Table China Supply, Consumption and Gap of Antidiabetic Biguanides 2011-2016 (Dose)

Table China Import, Export and Consumption of Antidiabetic Biguanides 2011-2016 (Dose)

Table Price of China Antidiabetic Biguanides Major Manufacturers 2011-2016 (USD/Dose)

Table Gross Margin of China Antidiabetic Biguanides Major Manufacturers 2011-2016

Table China and Major Manufacturers Revenue of Antidiabetic Biguanides 2011-2016 (M USD)

Table China Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Antidiabetic Biguanides 2011-2016

Table Sanofi Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Antidiabetic Biguanides Picture and Specifications of Sanofi

Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sanofi 2011-2016

Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Sanofi 2011-2016

Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Sanofi 2011-2016

Table Sanofi Antidiabetic Biguanides SWOT Analysis

Table Takeda Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Antidiabetic Biguanides Picture and Specifications of Takeda Pharmaceuticals

Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Takeda Pharmaceuticals 2011-2016

Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Takeda Pharmaceuticals 2011-2016

Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Takeda Pharmaceuticals 2011-2016

Table Takeda Pharmaceuticals Antidiabetic Biguanides SWOT Analysis

Table Eli Lilly Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Antidiabetic Biguanides Picture and Specifications of Eli Lilly

Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eli Lilly 2011-2016

Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Eli Lilly 2011-2016

Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Eli Lilly 2011-2016

Table Eli Lilly Antidiabetic Biguanides SWOT Analysis

Table Merck & Co. Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Antidiabetic Biguanides Picture and Specifications of Merck & Co.

Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck & Co. 2011-2016

Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Merck & Co. 2011-2016

Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Merck & Co. 2011-2016

Table Merck & Co. Antidiabetic Biguanides SWOT Analysis

Table Novo Nordisk Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Antidiabetic Biguanides Picture and Specifications of Novo Nordisk

Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016

Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Novo Nordisk 2011-2016

Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Novo Nordisk 2011-2016

Table Novo Nordisk Antidiabetic Biguanides SWOT Analysis

Table Bristol-Myers Squibb Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Antidiabetic Biguanides Picture and Specifications of Bristol-Myers Squibb

Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2011-2016

Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Bristol-Myers Squibb 2011-2016

Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Bristol-Myers Squibb 2011-2016

Table Bristol-Myers Squibb Antidiabetic Biguanides SWOT Analysis

Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Antidiabetic Biguanides Picture and Specifications of Pfizer

Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2011-2016

Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Pfizer 2011-2016

Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Pfizer 2011-2016

Table Pfizer Antidiabetic Biguanides SWOT Analysis

Table AstraZeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Antidiabetic Biguanides Picture and Specifications of AstraZeneca

Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016

Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of AstraZeneca 2011-2016

Figure Antidiabetic Biguanides Production (Dose) and China Market Share of AstraZeneca 2011-2016

Table AstraZeneca Antidiabetic Biguanides SWOT Analysis

Table GlaxoSmithKline Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Antidiabetic Biguanides Picture and Specifications of GlaxoSmithKline

Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2011-2016

Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of GlaxoSmithKline 2011-2016

Figure Antidiabetic Biguanides Production (Dose) and China Market Share of GlaxoSmithKline 2011-2016

Table GlaxoSmithKline Antidiabetic Biguanides SWOT Analysis

Table Boehringer Ingelheim Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Antidiabetic Biguanides Picture and Specifications of Boehringer Ingelheim

Table Antidiabetic Biguanides Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2011-2016

Figure Antidiabetic Biguanides Capacity (Dose), Production (Dose) and Growth Rate of Boehringer Ingelheim 2011-2016

Figure Antidiabetic Biguanides Production (Dose) and China Market Share of Boehringer Ingelheim 2011-2016

Table Boehringer Ingelheim Antidiabetic Biguanides SWOT Analysis

Table Antidiabetic Biguanides Price by Regions 2011-2016

Table Antidiabetic Biguanides Price by Product Types 2011-2016

Table Antidiabetic Biguanides Price by Companies 2011-2016

Table Antidiabetic Biguanides Gross Margin by Companies 2011-2016

Table Price Comparison of Antidiabetic Biguanides by Regions 2011-2016 (USD/Dose)

Table Price of Different Antidiabetic Biguanides Product Types (USD/Dose)

Table Market Share of Different Antidiabetic Biguanides Price Level

Table Gross Margin of Different Antidiabetic Biguanides Applications

Table Marketing Channels Status of Antidiabetic Biguanides

Table Traders or Distributors of Antidiabetic Biguanides with Contact Information

Table Ex-work Price, Channel Price and End Buyer Price of Antidiabetic Biguanides (USD/Dose) in 2015

Table China Import, Export, and Trade of Antidiabetic Biguanides (Dose)

Figure China Capacity (Dose), Production (Dose) and Growth Rate of Antidiabetic Biguanides 2016-2021

Figure China Capacity Utilization Rate of Antidiabetic Biguanides 2016-2021

Table China Antidiabetic Biguanides Production by Type 2016-2021 (Dose)

Table China Antidiabetic Biguanides Production Market Share by Type 2016-2021

Figure China Production Market Share of Antidiabetic Biguanides by Type in 2021

Figure China Sales (Dose) and Growth Rate of Antidiabetic Biguanides 2016-2021

Figure China Sales Revenue (Million USD) and Growth Rate of Antidiabetic Biguanides 2016-2021

Figure China Sales of Antidiabetic Biguanides by Applications 2016-2021 (Dose)

Table China Production Market Share of Antidiabetic Biguanides by Applications 2016-2021

Figure China Production Market Share of Antidiabetic Biguanides by Applications in 2021

Table China Production, Import, Export and Consumption of Antidiabetic Biguanides 2016-2021 (Dose)

Table China Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Antidiabetic Biguanides 2016-2021

Table Major Raw Materials Suppliers of Antidiabetic Biguanides with Contact Information

Table Manufacturing Equipment Suppliers of Antidiabetic Biguanides with Contact Information

Table Major Players of Antidiabetic Biguanides with Contact Information

Table Key Consumers of Antidiabetic Biguanides with Contact Information

Table Supply Chain Relationship Analysis of Antidiabetic Biguanides

Table New Project SWOT Analysis of Antidiabetic Biguanides

Table New Project Investment Feasibility Analysis of Antidiabetic Biguanides

Table Part of Interviewees Record List

Online Payment

Research Assistance
We will be happy to help you find what you need. Please write to us:

E-Addresssales@qyresearchreports.us